2. Academic Validation
  3. Discovery of A031 as effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer

Discovery of A031 as effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer

  • Eur J Med Chem. 2021 Apr 15;216:113307. doi: 10.1016/j.ejmech.2021.113307.
Linrong Chen 1,  Liuquan Han 2,  Shujun Mao 2,  Ping Xu 2,  Xinxin Xu 2,  Ruibo Zhao 1,  Zhihua Wu 3,  Kai Zhong 4,  Guangliang Yu 5,  Xiaolei Wang 6
Affiliations

Affiliations

  • 1 State Key Laboratory of Applied Organic Chemistry, Department of Chemistry, Lanzhou University, 222 S. Tianshui Rd, Lanzhou, 730000, PR China.
  • 2 Suzhou Degen Bio-medical Co., Ltd, No.1 Huayun Road, SIP, Suzhou, 215000, PR China.
  • 3 School of Pharmacy, Lanzhou University, 222 S. Tianshui Rd, Lanzhou, 730000, PR China.
  • 4 Suzhou Degen Bio-medical Co., Ltd, No.1 Huayun Road, SIP, Suzhou, 215000, PR China. Electronic address: 28328681@qq.com.
  • 5 Suzhou Degen Bio-medical Co., Ltd, No.1 Huayun Road, SIP, Suzhou, 215000, PR China. Electronic address: 41250230@qq.com.
  • 6 State Key Laboratory of Applied Organic Chemistry, Department of Chemistry, Lanzhou University, 222 S. Tianshui Rd, Lanzhou, 730000, PR China. Electronic address: Wangxiaolei@lzu.edu.cn.
PMID: 33652354 DOI: 10.1016/j.ejmech.2021.113307
Abstract

Androgen Receptor (AR) is an effective therapeutic target for the treatment of prostate Cancer. We report herein the design, synthesis, and biological evaluation of highly effective proteolysis targeting chimeras (PROTAC) Androgen Receptor (AR) degraders, such as compound A031. It could induce the degradation of AR protein in VCaP cell lines in a time-dependent manner, achieving the IC 50 value of less than 0.25 μM. The A031 is 5 times less toxic than EZLA and works with an appropriate half-life (t 1/2) or clearance rate (Cl). Also, it has a significant inhibitory effect on tumor growth in zebrafish transplanted with human prostate Cancer (VCaP). Therefore, A031 provides a further idea of developing novel drugs for prostate Cancer.

Keywords

Androgen receptor; E3 ligand; Human prostate cancer; PROTAC; VHL ligand.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验，部分功能也使用 Cookies 帮助我们更好地理解您的需求，为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问，请阅读我们的《隐私声明》。

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z